Will cost keep new Alzheimer's drug from patients?
Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.
Source: politico.com
Stay updated with breaking news from Vicky Leamy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.